MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Manganese"

  • 2025 International Congress

    Neuroprotective efficacy of EDTA against manganese neurotoxicity: Implications for modulating Parkinsonian syndromes

    H. Harifi, H. Hami, L. Bikjdaouene (Kenitra, Morocco)

    Objective: This study investigates the neuroprotective potential of ethylenediaminetetraacetic acid (EDTA) in reducing the neurotoxic effects of manganese (Mn), focusing on both motor and non-motor…
  • 2025 International Congress

    Ataxia, the initial symptom in a patient with Huntington’s Disease and Acquired (non-Wilsonian) Hepatocerebral Degeneration

    V. Montero, N. Valdés, á. Pontoni, P. Salles (Santiago de Chile, Chile)

    Objective: To describe a patient with Huntington disease and acquired (non-Wilsonian) hepatocerebral degeneration (AHD) presenting with ataxia. Background: AHD is a neurological disorder that occurs…
  • 2024 International Congress

    Manganese-induced Parkinsonism Vs Rotenone-induced Parkinsonism: Animal Life Matters!

    S. Chib (Bathinda, India)

    Objective: To evaluate the Parkinsonism mimicking potential of MnCl2 in an experimental rat model.To compare the destructive effect of MnCl2 with rotenone by performing behavioral,…
  • 2024 International Congress

    SLC39A8-CDG with manganese deficiency in an adult individual: a case report

    D. Cury Portela, T. Gonçalves Guimarães, G. Sousa Noleto, L. Sousa Araújo, I. Paula, S. Morais, V. Santana Vasconcelos (Teresina, Brazil)

    Objective: To report the case of an adult male with SLC39A8-CDG and evaluate the effects of manganese supplementation on clinical evolution of the patient. Background:…
  • 2023 International Congress

    A forgotten cause of ocular motor apraxia

    C. Azoia, C. Silva, A. Velon, A. Raimundo (Vila Real, Portugal)

    Objective: To report an example of the rare association between acquired hepatocerebral degeneration (AHD) and ocular motor apraxia (OA), and discuss its relevance for topical…
  • 2022 International Congress

    Therapeutic potential of luteolin in manganese induced Parkinson’s disease: Targeting neuroinflammation and oxidative stress.

    S. Chib (Moga, India)

    Objective: To investigate the neurodegenerative facets of Manganese (Mn) in rat model in rat model of Parkinson's disease.To study the neuroprotective effect of luteolin in…
  • 2022 International Congress

    Adults with slowly progressive dystonia-parkinsonism secondary to manganese accumulation

    R. Dayan, E. Linetzky, H. Mor-Shaked, M. Bauer, C. Muller, D. Arkadir (Jerusalem, Israel)

    Objective: To expand the clinical spectrum of manganese-induced neurodegeneration. Background: Neurodegeneration induced by manganese accumulation is a potentially treatable condition and therefore should not be…
  • MDS Virtual Congress 2021

    Clinical profile and treatment outcomes of inherited hypermanganesemia among 27 Indian children: A retrospective multi-centric study

    D. Garg, S. Yoganathan, A. Saini, N. Sankhyan, U. Kalane, K. Srivastava, A. Bothre, D. Panigrahi, M. Kamate, M. Juneja, V. Udani, S. Sharma (Delhi, India)

    Objective: To describe clinical, laboratory features and treatment outcomes among children with IH-Mn Background: Inherited hypermanganesemia (IH-Mn) is a recently described neurogenetic condition caused by mutations…
  • 2019 International Congress

    Inhibition of mitochondrial complexes induces unique transcriptomic and epigenetic profiles: implications to neurodegeneration induced movement disorders

    R. Sathyanarayanan, S. Bharath (Bangalore, India)

    Objective: To compare the neurotoxicological hallmarks induced by inhibitors of mitochondrial complex I (CI- 1- methyl-4- phenylpyridinium; MPP+), complex II (CII- 3- nitropropionic acid; 3-…
  • 2018 International Congress

    Toxin-induced Parkinsonism: A report of two patients

    Z. Aldaajani (Dhahran, Saudi Arabia)

    Objective: To highlight the presentation of parkinsonism caused by acute and chronic exposure to carbon monoxide(CO). Background: Toxin-induced parkinsonism is not uncommon. One of the…
  • 1
  • 2
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #29077 (not found)
  • #29056 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28189 (not found)
  • Welcome to the MDS Abstracts Site
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley